Korea BNC "Will Achieve Record-Breaking Performance This Year"

[Asia Economy Reporter Hyunseok Yoo] Korea BNC announced on the 2nd that it will achieve its highest-ever performance this year.

Korea BNC has grown through the commercialization of various bio-medical devices, focusing on dermal fillers and mesotherapy products using hyaluronic acid, as well as adhesion barriers and collagen-based tissue supplements. A Korea BNC official stated, "This year, Korea BNC will become a completely different company both qualitatively and quantitatively."

First, growth in the aesthetic plastic surgery field is expected. Korea BNC currently generates about 10 billion KRW in annual sales from medical devices such as fillers and mesotherapy product lines. The company official said, "Last October, we launched a dermocosmetic lineup led by skin boosters for clinics and hospitals, and the export of botulinum toxin, a prescription drug, is expected to begin in the first half of the year. We anticipate that sales of aesthetic plastic surgery-related product lines will double this year." He added, "The business synergy effect combining well-known medical devices (such as fillers), pharmaceuticals (botulinum toxin), and cosmetics (dermocosmetics) domestically and internationally will be fully realized."

Steady growth is also expected in non-aesthetic plastic surgery product lines. The adhesion barrier 'HyBarrier' and collagen absorbable wound dressing 'Zentacue,' used during surgical operations, have established themselves as the company's steady sellers. Additionally, the collagen-based tissue supplement 'Collapleo,' which aids tissue regeneration in ligament and muscle tears, is receiving enthusiastic market responses, according to the company.

Korea BNC expects the completion of an advanced pharmaceutical GMP factory currently under construction in Sejong Special City this year. A company official said, "With a building area more than five times that of the existing Daegu plant, after the completion of the Sejong plant, Korea BNC will demonstrate research and development achievements in various advanced bio-pharmaceuticals and pharmaceutical substances that will astonish the world, along with mass production of botulinum toxin."

This content was produced with the assistance of AI translation services.